SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-076335
Filing Date
2022-06-30
Accepted
2022-06-30 16:44:46
Documents
13
Period of Report
2022-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220088d1_8k.htm   iXBRL 8-K 37747
2 EXHIBIT 10.1 tm2220088d1_ex10-1.htm EX-10.1 220078
  Complete submission text file 0001104659-22-076335.txt   481506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mxct-20220629.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20220629_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20220629_pre.xml EX-101.PRE 22593
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2220088d1_8k_htm.xml XML 3703
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 221058515
SIC: 8731 Services-Commercial Physical & Biological Research